JPWO2021248111A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021248111A5 JPWO2021248111A5 JP2022574660A JP2022574660A JPWO2021248111A5 JP WO2021248111 A5 JPWO2021248111 A5 JP WO2021248111A5 JP 2022574660 A JP2022574660 A JP 2022574660A JP 2022574660 A JP2022574660 A JP 2022574660A JP WO2021248111 A5 JPWO2021248111 A5 JP WO2021248111A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- virus
- fragment
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 241000700605 Viruses Species 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- 241000711573 Coronaviridae Species 0.000 claims description 8
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 7
- 230000000975 bioactive effect Effects 0.000 claims description 6
- 230000000840 anti-viral effect Effects 0.000 claims description 5
- 241001678559 COVID-19 virus Species 0.000 claims description 2
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims description 2
- 241000315672 SARS coronavirus Species 0.000 claims description 2
- 208000036142 Viral infection Diseases 0.000 claims description 2
- 239000003443 antiviral agent Substances 0.000 claims description 2
- 241001493065 dsRNA viruses Species 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 210000005007 innate immune system Anatomy 0.000 claims description 2
- 238000007912 intraperitoneal administration Methods 0.000 claims description 2
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 238000007920 subcutaneous administration Methods 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 230000009385 viral infection Effects 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 description 22
- 239000000919 ceramic Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- -1 skin Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035733P | 2020-06-06 | 2020-06-06 | |
| US63/035,733 | 2020-06-06 | ||
| PCT/US2021/036104 WO2021248111A1 (en) | 2020-06-06 | 2021-06-07 | Materials and methods for inhibiting a viral infection, including a coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529152A JP2023529152A (ja) | 2023-07-07 |
| JPWO2021248111A5 true JPWO2021248111A5 (zh) | 2024-06-11 |
Family
ID=78831585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574660A Pending JP2023529152A (ja) | 2020-06-06 | 2021-06-07 | コロナウイルス感染を含むウイルス感染を阻害するための物質および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11826390B2 (zh) |
| EP (1) | EP4161558A4 (zh) |
| JP (1) | JP2023529152A (zh) |
| KR (1) | KR20230025853A (zh) |
| CN (1) | CN116133669A (zh) |
| AU (1) | AU2021286002A1 (zh) |
| BR (1) | BR112022024911A2 (zh) |
| CA (1) | CA3180737A1 (zh) |
| IL (1) | IL298401A (zh) |
| MX (1) | MX2022015439A (zh) |
| WO (1) | WO2021248111A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3156574A1 (en) * | 2019-11-26 | 2021-09-30 | Quorum Innovations, Llc | Novel protective barrier compositions, and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002951270A0 (en) * | 2002-09-06 | 2002-09-19 | Vri Biomedical Ltd | Probiotic Bacterium and Methods of Use |
| DK1951273T3 (da) * | 2005-10-06 | 2014-05-05 | Probi Ab | Anvendelse af lactobacillus til behandling af autoimmune sygdomme |
| RU2500412C2 (ru) * | 2008-09-04 | 2013-12-10 | Ом Фарма | ИММУНОМОДУЛИРУЮЩИЕ ЭКСТРАКТЫ ИЗ БАКТЕРИЙ Lactobacillus И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
| KR101378608B1 (ko) * | 2011-04-13 | 2014-03-27 | 씨제이제일제당 (주) | 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주 |
| WO2017015275A1 (en) * | 2015-07-20 | 2017-01-26 | Quorum Innovations, Llc | Materials and methods for improving immune responses and the skin and/or mucosal barrier function |
| CN115776986A (zh) * | 2020-05-06 | 2023-03-10 | 群体创新有限责任公司 | 新型蛋白质及其治疗和美容用途 |
-
2021
- 2021-06-07 KR KR1020237000014A patent/KR20230025853A/ko unknown
- 2021-06-07 IL IL298401A patent/IL298401A/en unknown
- 2021-06-07 AU AU2021286002A patent/AU2021286002A1/en active Pending
- 2021-06-07 CA CA3180737A patent/CA3180737A1/en active Pending
- 2021-06-07 MX MX2022015439A patent/MX2022015439A/es unknown
- 2021-06-07 JP JP2022574660A patent/JP2023529152A/ja active Pending
- 2021-06-07 EP EP21816956.3A patent/EP4161558A4/en active Pending
- 2021-06-07 US US17/418,440 patent/US11826390B2/en active Active
- 2021-06-07 CN CN202180059965.6A patent/CN116133669A/zh active Pending
- 2021-06-07 BR BR112022024911A patent/BR112022024911A2/pt unknown
- 2021-06-07 WO PCT/US2021/036104 patent/WO2021248111A1/en unknown
-
2023
- 2023-10-25 US US18/493,979 patent/US20240075083A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016109940A (ru) | Вакцина против бешенства | |
| JP5209462B2 (ja) | コンセンサスインターフェロンの使用方法 | |
| JP2007531741A5 (zh) | ||
| US9982028B2 (en) | Recombinant human interferon-like proteins | |
| RU2016109937A (ru) | Вакцина против респираторно-синцитиального вируса (рсв) | |
| IL276210B2 (en) | MERS-COV vaccine | |
| AR021876A1 (es) | Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado | |
| EP1797112B1 (en) | Inhibitors of hepatitits c virus | |
| EA201000085A1 (ru) | dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ | |
| WO2021000968A3 (zh) | 一种用于预防SARS-CoV-2感染的腺病毒载体疫苗 | |
| RU2011122615A (ru) | Живой аттенуированный респираторно-синцитиальный вирус | |
| JP2013523718A5 (zh) | ||
| Ding et al. | Characterization and function of a group II type I interferon in the perciform fish, large yellow croaker (Larimichthys crocea) | |
| MXPA05005203A (es) | Vacuna contra vhc. | |
| US20070141080A1 (en) | Treating severe acute respiratory syndrome | |
| WO2017222295A1 (ko) | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 | |
| KR20210013136A (ko) | 미생물 감염의 치료에서 사용을 위한 딜티아젬 | |
| JPWO2021248111A5 (zh) | ||
| US8075877B2 (en) | Broad spectrum immune and antiviral gene modulation by oral interferon | |
| JP2005508158A5 (zh) | ||
| WO2020108427A1 (zh) | 一种新型干扰素α及其制备方法、组合物和用途 | |
| JP2008503569A5 (zh) | ||
| RU2318872C2 (ru) | Рекомбинантные штаммы вируса гриппа, экспрессирующие микобактериальный протективный антиген esat-6, и их использование для профилактики и лечения туберкулеза | |
| JP2007516214A5 (zh) | ||
| CN111358813B (zh) | 一种用于保护呼吸道的盐雾混合物 |